Singhe Hospitals Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Amarakone Weerasinghe

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	86.4%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	6.5yrs

Son yönetim güncellemeleri

Recent updates

CEO

Amarakone Weerasinghe

no data

Görev süresi

Mr. Amarakone Mudiyanselage Weerasinghe serves as the Chairman, Chief Executive Officer and Executive Director of Singhe Hospitals Plc (Singhe Hospitals Pvt Ltd). Mr. Weerasinghe serves as the Chairman of...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Amarakone Weerasinghe	Chairman & CEO	no data	Veri yok	86.41% LKR 931.7m
Amarakoon Lakshika Weerasinghe	Marketing Director & Executive Director	no data	Veri yok	Veri yok
Amarakoon M. D. H. Weerasinghe	MD & Executive Director	no data	Veri yok	0% LKR 0
Aznayn Mohiadeen Cader	Independent Non-Executive Director	9.3yrs	Veri yok	Veri yok
H. M. A. Weerasekara	Senior Independent Director	9.5yrs	Veri yok	Veri yok
Aruna Jayakody	Independent Non Executive Director	less than a year	Veri yok	Veri yok
Amarakoon Mudiyanselage Navanjana Weerasinghe	Non-Executive-Non Independent Director	3.7yrs	Veri yok	Veri yok
Uggal Bawula Hewagamage Kithsiri	Independent Non-Executive Director	13.6yrs	Veri yok	0.26% LKR 2.7m
Chaaminda Kumarasiri	Non-Executive Independent Director	less than a year	Veri yok	Veri yok

6.5yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: SINH.N0000 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.5 yıldır).

Singhe Hospitals Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Singhe Hospitals PLC, Annual General Meeting, Aug 22, 2024

Insufficient new directors

Independent Non-Executive Director recently bought LK₨2.3m worth of stock

Independent Non-Executive Director recently sold LK₨124k worth of stock

Chairman & CEO recently sold LK₨433k worth of stock

Recent updates

Second quarter 2025 earnings released: EPS: LK₨0.04 (vs LK₨0.03 loss in 2Q 2024)

First quarter 2025 earnings released: EPS: LK₨0.02 (vs LK₨0.05 loss in 1Q 2024)

Singhe Hospitals PLC, Annual General Meeting, Aug 22, 2024

New major risk - Share price stability

Full year 2024 earnings released: EPS: LK₨0 (vs LK₨0.024 in FY 2023)

New minor risk - Share price stability

Insufficient new directors

Third quarter 2024 earnings released: EPS: LK₨0.03 (vs LK₨0.04 in 3Q 2023)

New major risk - Share price stability

First quarter 2024 earnings released: LK₨0.05 loss per share (vs LK₨0.01 loss in 1Q 2023)

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: LK₨0.024 (vs LK₨0.038 in FY 2022)

Full year 2023 earnings released: EPS: LK₨0.03 (vs LK₨0.038 in FY 2022)

Third quarter 2023 earnings released: EPS: LK₨0.04 (vs LK₨0.005 in 3Q 2022)

First quarter 2023 earnings released: LK₨0.01 loss per share (vs LK₨0 in 1Q 2022)

Full year 2022 earnings released: EPS: LK₨0.04 (vs LK₨0.005 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS LK₨0.02 (vs LK₨0.01 in 2Q 2021)

Independent Non-Executive Director recently bought LK₨2.3m worth of stock

Third quarter 2021 earnings released: LK₨0.01 loss per share (vs LK₨0.029 profit in 3Q 2020)

New 90-day low: LK₨2.50

Independent Non-Executive Director recently sold LK₨124k worth of stock

Chairman & CEO recently sold LK₨433k worth of stock

New 90-day high: LK₨3.00

New 90-day high: LK₨2.10

New 90-day high - LK₨1.80

CEO

Görev süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi